Mei-Lang Kung Selected Research

hepatoma-derived growth factor

12/2020	Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis.
1/2019	Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis.
6/2015	Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis.
6/2013	Downregulation of hepatoma-derived growth factor contributes to retarded lung metastasis via inhibition of epithelial-mesenchymal transition by systemic POMC gene delivery in melanoma.
1/2013	Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected].
10/2012	Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
8/2012	Hepatoma-derived growth factor stimulates podosome rosettes formation in NIH/3T3 cells through the activation of phosphatidylinositol 3-kinase/Akt pathway.
3/2012	Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei-Lang Kung Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 01/2003
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 01/2003
5	Carcinogenesis 12/2020 - 03/2012
4	Melanoma (Melanoma, Malignant) 10/2020 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2012
2	Infections 01/2019 - 07/2017
1	Carcinoma (Carcinomatosis) 01/2022
1	Mouth Neoplasms (Oral Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 09/2021
1	Anxiety Disorders (Anxiety Disorder) 09/2021
1	Inflammation (Inflammations) 08/2021
1	Fibrosis (Cirrhosis) 12/2020
1	Hepatitis 12/2020
1	Colorectal Neoplasms (Colorectal Cancer) 10/2020
1	Lymphatic Metastasis 01/2019
1	Gastritis 01/2019
1	Cross Infection (Nosocomial Infection) 07/2017
1	Mood Disorders (Mood Disorder) 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 10/2016
1	Amyloidosis 10/2016
1	Pathologic Processes 03/2016
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2015
1	Liver Neoplasms (Liver Cancer) 03/2014
1	Experimental Liver Neoplasms 03/2014
1	Breast Neoplasms (Breast Cancer) 10/2012
1	Glioma (Gliomas) 03/2012
1	Neuroblastoma 08/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2004

Drug/Important Bio-Agent (IBA)

8	hepatoma-derived growth factorIBA 12/2020 - 03/2012
4	Biological ProductsIBA 09/2021 - 02/2004
3	Pharmaceutical PreparationsIBA 09/2021 - 03/2014
3	Cadherins (E-Cadherin)IBA 01/2019 - 10/2012
2	zingeroneIBA 01/2022 - 01/2019
2	PhytochemicalsIBA 01/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2012
2	Long Noncoding RNAIBA 09/2021 - 10/2020
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 09/2021 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 03/2016
2	LigandsIBA 01/2019 - 01/2018
2	VimentinIBA 06/2013 - 10/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 03/2012
2	Phosphotransferases (Kinase)IBA 02/2004 - 01/2003
2	GenisteinIBA 02/2004 - 01/2003
2	IsoflavonesIBA 02/2004 - 01/2003
1	Metformin (Glucophage)FDA LinkGeneric 09/2021
1	Fluoxetine (Prozac)FDA LinkGeneric 09/2021
1	graphene oxideIBA 08/2021
1	Concanavalin AIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Sodium AzideIBA 10/2020
1	FlavonoidsIBA 01/2020
1	protoapigenoneIBA 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2017
1	SilverIBA 07/2017
1	CopperIBA 07/2017
1	OxidesIBA 07/2017
1	Amyloid (Amyloid Fibrils)IBA 10/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2015
1	AntibodiesIBA 06/2015
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2015
1	NucleolinIBA 06/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 03/2014
1	Celecoxib (Celebrex)FDA Link 03/2014
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 06/2013
1	Hormones (Hormone)IBA 06/2013
1	Peptides (Polypeptides)IBA 06/2013
1	Proteins (Proteins, Gene)FDA Link 10/2012
1	Toll-Like Receptor 3IBA 08/2011
1	Caspase 3 (Caspase-3)IBA 01/2003
1	daidzeinIBA 01/2003
1	biochanin AIBA 01/2003
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2003

Therapy/Procedure

7	Therapeutics 01/2022 - 06/2013
3	Chemoprevention 01/2022 - 01/2019
1	Drug Therapy (Chemotherapy) 10/2020
1	Adjuvant Chemotherapy 01/2020